Quipt Home Medical (TSX:QIPT) Research & Development: C$0.0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSX:QIPT Quipt Home Medical Corp TSX:QIPT
59 GF Score
Price C$4.98
GF Value C$5.14
! 7 Warning Signs
View Full Analysis

What is Quipt Home Medical Research & Development?

Quipt Home Medical TSX:QIPT +0.40% 59 Research & Development is C$0.0 Mil as of Dec. 2025. GuruFocus rates TSX:QIPT with a GF Score™ of 59/100 and a GF Value™ of C$5.14. The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Quipt Home Medical's Research & Development for the three months ended in Dec. 2025 was C$0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was C$0.0 Mil.

Quipt Home Medical  (TSX:QIPT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Quipt Home Medical Research & Development Related Terms

Quipt Home Medical Research & Development Historical Data

* Premium members only.

The historical data trend for Quipt Home Medical's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quipt Home Medical Research & Development Chart

Quipt Home Medical Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Quipt Home Medical Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSX:QIPT
59GF Score
Quipt Home Medical Corp TSX:QIPT
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Quipt Home Medical Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of C$0.0 Mil mean?
Quipt Home Medical (TSX:QIPT) has a Research & Development of C$0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Quipt Home Medical and its competitors.
Is Quipt Home Medical's Research & Development too high?
Quipt Home Medical's current Research & Development is C$0.0 Mil. Overall, Quipt Home Medical has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Quipt Home Medical's Research & Development compare to ACH and EDAP?
Quipt Home Medical's Research & Development of C$0.0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Distribution company?
A good Research & Development depends on the Medical Distribution industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Quipt Home Medical and its competitors. Quipt Home Medical's current Research & Development is C$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quipt Home Medical stock overvalued right now?
Quipt Home Medical (TSX:QIPT) has a current Research & Development of C$0.0 Mil. The stock's GF Value™ is C$5.14, compared to a current price of C$4.98 — trading 3.1% below its estimated fair value. The current Research & Development is C$0.0 Mil. Quipt Home Medical's overall GF Score™ is 59/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Quipt Home Medical (TSX:QIPT), the current Research & Development is C$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Quipt Home Medical (TSX:QIPT) Overvalued in 2026?

Based on GuruFocus' analysis, Quipt Home Medical stock appears to be undervalued. The current stock price of C$4.98 is trading 3.1% below its estimated GF Value™ of C$5.14.

Key valuation signals for TSX:QIPT:

  • Research & Development: C$0.0 Mil
  • GF Value™: C$5.14 vs. price of C$4.98 (3.1% below fair value)
  • GF Score™: 59/100 with 7 warning signs

No single metric tells the full story. See the TSX:QIPT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Quipt Home Medical Business Description

Address 1019 Town Drive, Wilder, KY, USA, 41076
Quipt Home Medical Corp is a provider of durable medical equipment (DME) and home medical equipment (HME) in the United States. The Company specializes in delivering in-home treatments for the management of chronic conditions, with a primary focus on respiratory diseases, and supports patients with heart and pulmonary diseases, sleep apnea, reduced mobility, and other chronic health challenges. Its products and services include Sleep Apnea and PAP treatment, home medical equipment, home ventilation, and custom mobility solutions. The Company operates in a single business segment, comprising the sale and rental of medical equipment and related devices, and serves patients across 27 states in the United States.
59GF Score

Get the complete analysis for TSX:QIPT

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$4.98
Price
C$5.14
GF Value